Munich Re names Christoph Jurecka as next board chair

Predecessor set to retire after leading the Ambition 2025 strategy

Munich Re names Christoph Jurecka as next board chair

Reinsurance News

By Kenneth Araullo

Munich Re has confirmed a series of changes to its board of management, including the planned departure of current chair Dr. Joachim Wenning and the appointment of his successor.

Wenning, 60, will step down from his role at the end of 2025. He informed the supervisory board that he does not intend to seek an extension of his mandate, citing personal reasons. His retirement will coincide with the completion of Munich Re’s Ambition 2025 strategy program.

The supervisory board has named Dr. Christoph Jurecka (pictured above) as the incoming chair of the board of management, effective Jan. 1, 2026.

Jurecka, 50, joined Munich Re in 2011 as a member of the board of management of ERGO Group AG. Since 2019, he has served as Munich Re’s chief financial officer.

“The supervisory board expresses its gratitude to Joachim Wenning both for his outstanding performance over the decades he has worked at Munich Re and for his eight-year tenure at the helm,” supervisory board chair Dr. Nikolaus von Bomhard said.

Also taking effect Jan. 1, 2026, Andrew Buchanan will join the board of management and assume the role of chief financial officer. Buchanan, 47, has been with Munich Re since 2011 and has served as CFO of the reinsurance business segment since 2017. Originally from South Africa, he will succeed Jurecka as group CFO.

In addition, the supervisory board has appointed Robin Johnson to the board of management, effective Aug. 1, 2025. Johnson, 57, will take on the newly created position of chief technology officer.

He has served as chief information officer for the reinsurance business since 2017 and, since 2023, has held an additional CTO position on the board of management of ERGO Group AG. He also chairs the board of management of ERGO Technology & Services Management AG.

Munich Re’s current board of directors is as follows:

  • Dr. Joachim Wenning – chair of the board of management
  • Dr. Thomas Blunck – chair of the reinsurance committee
  • Nicholas Gartside – chief investment officer
  • Stefan Golling –responsible for Global Clients & North America, Capital Partners
  • Dr. Christoph Jurecka – chief financial officer, chair of the group risk committee
  • Dr. Achim Kassow – labor relations director
  • Michael Kerner – responsible for global specialty insurance
  • Clarisse Kopff – responsible for Europe and Latin America
  • Mari‑Lizette Malherbe – responsible for life and health
  • Dr. Markus Rieß – responsible for primary insurance/ERGO

The announcement comes as Munich Re reported second-quarter 2025 earnings of €2.1 billion, exceeding analyst expectations of €1.62 billion. The 30% year-over-year increase in net profit was supported by a lower-than-expected burden from major losses.

Munich Re reiterated its full-year profit guidance of €6 billion, indicating confidence in its underlying performance despite volatile risk conditions. A full breakdown of the Q2 results is scheduled for Aug. 8.

What are your thoughts on this story? Please feel free to share your comments below.

Related Stories

Keep up with the latest news and events

Join our mailing list, it’s free!